Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Sleeping Beauty is a non-viral transposon/transposase system licensed from the University of Texas MD Anderson Cancer Center that stably reprograms immune cells by inserting specific DNA sequences into their genome.”
FILING10-K0001356090-26-000009cik 0001356090
“We had selected Eversana, a leading provider of commercialization services to the global life sciences industry, to support launch strategy and commercialization of Papzimeos in the United States.”
FILING10-K0001356090-26-000009cik 0001356090
“On September 3, 2025, we and certain of our subsidiaries party thereto as guarantors entered into a Loan Agreement (the "Loan Agreement") with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership as the lenders thereunder (the "Lenders") and BioPharma Credit PLC as the collateral agent, each of which are investment entities managed by Pharmakon Advisors, LP.”
FILING10-K0001356090-26-000009cik 0001356090
“On September 3, 2025, we and certain of our subsidiaries party thereto as guarantors entered into a Loan Agreement (the "Loan Agreement") with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership as the lenders thereunder (the "Lenders") and BioPharma Credit PLC as the collateral agent, each of which are investment entities managed by Pharmakon Advisors, LP.”
FILING10-K0001356090-26-000009cik 0001356090
“On September 3, 2025, we and certain of our subsidiaries party thereto as guarantors entered into a Loan Agreement (the "Loan Agreement") with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership as the lenders thereunder (the "Lenders") and BioPharma Credit PLC as the collateral agent, each of which are investment entities managed by Pharmakon Advisors, LP.”
FILING10-K0001356090-26-000009cik 0001356090
“In addition, we announced a plan to continue PRGN-2009 Phase 2 clinical trials under a cooperative research and development agreement ("CRADA") with the National Cancer Institute ("NCI") in recurrent/metastatic cervical cancer and in newly diagnosed HPV-associated oropharyngeal cancer.”
FILING10-K0001356090-26-000009cik 0001356090
“We have historically been controlled and principally funded by Randal J. Kirk, our Executive Chairman, and affiliates of Mr. Kirk, including Third Security.”
FILING10-K0001356090-26-000009cik 0001356090
“We have historically been controlled and principally funded by Randal J. Kirk, our Executive Chairman, and affiliates of Mr. Kirk, including Third Security.”
FILING10-K0001356090-26-000009cik 0001356090
“Papzimeos is also covered under Medicare and Medicaid.”
FILING10-K0001356090-26-000009cik 0001356090
“Papzimeos is also covered under Medicare and Medicaid.”
FILING10-K0001356090-26-000009cik 0001356090
“In September 2025, the Company and PTC Therapeutics mutually agreed to terminate their existing exclusive channel collaboration ("ECC") agreement.”
FILING10-K0001356090-26-000009cik 0001356090
Watchlist prices, news filtered to it, and its next report on your desk.
Precigen, Inc. has 8 disclosed suppliers and 3 disclosed customers. Each one is named in an SEC filing, either Precigen, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
PGEN (Precigen, Inc.) has 8 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: PTCT −0.01%, in healthcare.
Prev close 7.00 · gapped below the open, then crossed back over prior close. High/low 7.02 at 5:30 pm ET, 6.80 at 9:30 am ET.
Precigen, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations